Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 8/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2102444 | 1.00 | HCAR2 (0.56) | HCAR2ACHEBACE1ATMCTSK | |
| SCHEMBL2099288 | 1.00 | HCAR2 (0.56) | HCAR2ACHEBACE1ATMCTSK | |
| SCHEMBL2102347 | 0.98 | HCAR2 (0.57) | HCAR2ACHEBACE1GPR84FFAR1 | |
| Fumaric Acid SCHEMBL10951830 | 0.98 | HCAR2 (0.57) | HCAR2ACHEBACE1GPR84FFAR1 | |
| SCHEMBL10385864 | 0.98 | HCAR2 (0.57) | HCAR2ACHEBACE1GPR84FFAR1 | |
| SCHEMBL2101148 | 0.98 | HCAR2 (0.57) | HCAR2ACHEBACE1GPR84FFAR1 | |
| SCHEMBL10385862 | 0.98 | HCAR2 (0.57) | HCAR2ACHEBACE1GPR84FFAR1 | |
| SCHEMBL2101146 | 0.98 | HCAR2 (0.57) | HCAR2ACHEBACE1GPR84FFAR1 | |
| SCHEMBL5611250 | 0.98 | HCAR2 (0.58) | HCAR2ACHEBACE1ATMGPR84 | |
| SCHEMBL5611251 | 0.98 | HCAR2 (0.58) | HCAR2ACHEBACE1ATMGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2598470-B1 | FORMULATIONS | SYNGENTA LTD (GB) | 2021-01-20 | — | — | EP | disclosed |
| US-9458085-B2 | Formulations | SYNGENTA LIMITED (GB) | 2016-10-04 | — | — | US | disclosed |
| US-20140249328-A1 | FORMULATIONS | SYNGENTA LIMITED (GB) | 2014-09-04 | — | — | US | disclosed |
| US-8163458-B2 | Method of manufacturing toner, toner, two-component developer, developing device, and image forming apparatus | SHARP KABUSHIKI KAISHA (JP) | 2012-04-24 | — | — | US | disclosed |
| US-7713675-B2 | Method of manufacturing toner | SHARP KABUSHIKI KAISHA (JP) | 2010-05-11 | — | — | US | disclosed |
| US-7704664-B2 | Method of manufacturing toner and toner | SHARP KABUSHIKI KAISHA (JP) | 2010-04-27 | — | — | US | disclosed |
| US-7575843-B2 | Method of manufacturing toner and toner | SHARP KABUSHIKI KAISHA (JP) | 2009-08-18 | — | — | US | disclosed |
| EP-1262838-B1 | RESIN COMPOSITION FOR TONER AND TONER | MITSUI CHEMICALS INC (JP) | 2009-01-21 | — | — | EP | disclosed |
| US-20090011351-A1 | METHOD OF MANUFACTURING TONER, TONER, TWO-COMPONENT DEVELOPER, DEVELOPING DEVICE, AND IMAGE FORMING APPARATUS | SHARP KABUSHIKI KAISHA (JP) | 2009-01-08 | — | — | US | disclosed |
| US-20070202433-A1 | Method of manufacturing toner | SHARP KABUSHIKI KAISHA (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070196754-A1 | Method of manufacturing toner and toner | SHARP KABUSHIKI KAISHA (JP) | 2007-08-23 | — | — | US | disclosed |
| US-20070166638-A1 | Method of manufacturing toner and toner | SHARP KABUSHIKI KAISHA (JP) | 2007-07-19 | — | — | US | disclosed |
| US-6733941-B1 | ETHYLENE POLYMER, PARAFFIN WAX AND BINDER; LOW TEMPERATURE FIXATION, OFFSET RESISTANCE, PRESERVING IMAGE QUALITY | MITSUI CHEMICALS, INC. (JP) | 2004-05-11 | — | — | US | disclosed |
| EP-1262838-A1 | RESIN COMPOSITION FOR TONER AND TONER | Mitsui Chemicals, Inc. (JP) | 2002-12-04 | — | — | EP | disclosed |
| EP-0756208-B1 | Resin composition for electrophotographic toner, and toner comprising it | MITSUI CHEMICALS INC (JP) | 2001-04-11 | — | — | EP | disclosed |
| US-6011119-A | RESIN COMPOSITION SHOWS EXCELLENT CHARGING CHARACTERISTICS WITHOUT A CHARGE CONTROL AGENT; HIGH AND LOW MOLECULAR WEIGHT ADDITION POLYMERS AT LEAST ONE OF WHICH IS FROM AN UNSATURATED ANHYDRIDE AND AN ACRYLOYLOXYALKYL DICARBOXYLIC ACID ESTER | MITSUI CHEMICALS, INC. (JP) | 2000-01-04 | — | — | US | disclosed |
| EP-0756208-A1 | Resin composition for electrophotographic toner, and toner comprising it | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1997-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249328-A1 | FORMULATIONS | C5, C1S, C1R | HCAR2 1504/4885ACHE 2127/4885BACE1 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.